These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
724 related articles for article (PubMed ID: 27769943)
1. Mucoadhesive chitosan hydrogels as rectal drug delivery vessels to treat ulcerative colitis. Xu J; Tam M; Samaei S; Lerouge S; Barralet J; Stevenson MM; Cerruti M Acta Biomater; 2017 Jan; 48():247-257. PubMed ID: 27769943 [TBL] [Abstract][Full Text] [Related]
2. Genipin-crosslinked catechol-chitosan mucoadhesive hydrogels for buccal drug delivery. Xu J; Strandman S; Zhu JX; Barralet J; Cerruti M Biomaterials; 2015 Jan; 37():395-404. PubMed ID: 25453967 [TBL] [Abstract][Full Text] [Related]
3. Mucoadhesive and thermosensitive Bletilla striata polysaccharide/chitosan hydrogel loaded nanoparticles for rectal drug delivery in ulcerative colitis. Zhao S; Zhang J; Qiu M; Hou Y; Li X; Zhong G; Gou K; Li J; Zhang C; Qu Y; Wang X Int J Biol Macromol; 2024 Jan; 254(Pt 1):127761. PubMed ID: 38287598 [TBL] [Abstract][Full Text] [Related]
4. Measurement of colonic mucosal concentrations of 5-aminosalicylic acid is useful for estimating its therapeutic efficacy in distal ulcerative colitis: comparison of orally administered mesalamine and sulfasalazine. Naganuma M; Iwao Y; Ogata H; Inoue N; Funakoshi S; Yamamoto S; Nakamura Y; Ishii H; Hibi T Inflamm Bowel Dis; 2001 Aug; 7(3):221-5. PubMed ID: 11515848 [TBL] [Abstract][Full Text] [Related]
5. Oral Delivery of Nanoparticles Loaded With Ginger Active Compound, 6-Shogaol, Attenuates Ulcerative Colitis and Promotes Wound Healing in a Murine Model of Ulcerative Colitis. Zhang M; Xu C; Liu D; Han MK; Wang L; Merlin D J Crohns Colitis; 2018 Jan; 12(2):217-229. PubMed ID: 28961808 [TBL] [Abstract][Full Text] [Related]
6. Temperature-sensitive hydrogel for rectal perfusion improved the therapeutic effect of Kangfuxin liquid on DSS-induced ulcerative colitis mice: The inflammation alleviation and the colonic mucosal barriers repair. Xue P; Wang L; Xu J; Liu J; Pan X; Zhao Y; Xu H Int J Pharm; 2020 Nov; 589():119846. PubMed ID: 32891717 [TBL] [Abstract][Full Text] [Related]
7. A meta-analysis of the efficacy of sulfasalazine in comparison with 5-aminosalicylates in the induction of improvement and maintenance of remission in patients with ulcerative colitis. Nikfar S; Rahimi R; Rezaie A; Abdollahi M Dig Dis Sci; 2009 Jun; 54(6):1157-70. PubMed ID: 18770034 [TBL] [Abstract][Full Text] [Related]
8. Tailoring the mucoadhesive and sustained release characteristics of mesalamine loaded formulations for local treatment of distal forms of ulcerative colitis. Ali HS; Hanafy AF; El Achy SN Eur J Pharm Sci; 2016 Oct; 93():233-43. PubMed ID: 27503459 [TBL] [Abstract][Full Text] [Related]
9. Orally Targeted Delivery of Tripeptide KPV via Hyaluronic Acid-Functionalized Nanoparticles Efficiently Alleviates Ulcerative Colitis. Xiao B; Xu Z; Viennois E; Zhang Y; Zhang Z; Zhang M; Han MK; Kang Y; Merlin D Mol Ther; 2017 Jul; 25(7):1628-1640. PubMed ID: 28143741 [TBL] [Abstract][Full Text] [Related]
10. Anti-inflammatory effects of Pulvis Fellis Suis extract in mice with ulcerative colitis. He J; Liang J; Zhu S; Li J; Zhang Y; Sun W J Ethnopharmacol; 2011 Oct; 138(1):53-9. PubMed ID: 21872653 [TBL] [Abstract][Full Text] [Related]
11. N-Succinyl-chitosan systems for 5-aminosalicylic acid colon delivery: in vivo study with TNBS-induced colitis model in rats. Mura C; Nácher A; Merino V; Merino-Sanjuan M; Carda C; Ruiz A; Manconi M; Loy G; Fadda AM; Diez-Sales O Int J Pharm; 2011 Sep; 416(1):145-54. PubMed ID: 21723929 [TBL] [Abstract][Full Text] [Related]
12. Novel pH-sensitive hydrogels for 5-aminosalicylic acid colon targeting delivery: in vivo study with ulcerative colitis targeting therapy in mice. Bai XY; Yan Y; Wang L; Zhao LG; Wang K Drug Deliv; 2016 Jul; 23(6):1926-32. PubMed ID: 25693641 [TBL] [Abstract][Full Text] [Related]
13. Anti-inflammatory effect of taurocholate on TNBS-induced ulcerative colitis in mice. Yang Y; He J; Suo Y; Lv L; Wang J; Huo C; Zheng Z; Wang Z; Li J; Sun W; Zhang Y Biomed Pharmacother; 2016 Jul; 81():424-430. PubMed ID: 27261622 [TBL] [Abstract][Full Text] [Related]
14. Chitosan-catechol: a polymer with long-lasting mucoadhesive properties. Kim K; Kim K; Ryu JH; Lee H Biomaterials; 2015 Jun; 52():161-70. PubMed ID: 25818422 [TBL] [Abstract][Full Text] [Related]
15. Pharmacotherapy of inflammatory bowel disease. Part 1. Sulfasalazine. Das KM Postgrad Med; 1983 Dec; 74(6):141-8, 150-1. PubMed ID: 6139795 [TBL] [Abstract][Full Text] [Related]
16. Chitosan capsules for colon-specific drug delivery: enhanced localization of 5-aminosalicylic acid in the large intestine accelerates healing of TNBS-induced colitis in rats. Tozaki H; Odoriba T; Okada N; Fujita T; Terabe A; Suzuki T; Okabe S; Muranishi S; Yamamoto A J Control Release; 2002 Jul; 82(1):51-61. PubMed ID: 12106976 [TBL] [Abstract][Full Text] [Related]
17. Discovery and preclinical development of a novel prodrug conjugate of mesalamine with eicosapentaenoic acid and caprylic acid for the treatment of inflammatory bowel diseases. Kandula M; Sunil Kumar KB; Palanichamy S; Rampal A Int Immunopharmacol; 2016 Nov; 40():443-451. PubMed ID: 27716592 [TBL] [Abstract][Full Text] [Related]
18. Mucoadhesive Nanoparticles Enhance the Therapeutic Effect of Dexamethasone on Experimental Ulcerative Colitis by the Local Administration as an Enema. Dong K; Deng SJ; He BY; Guo ZY; Guan ZL; Leng X; Ma RR; Wang DY; Xing JF; You CY Drug Des Devel Ther; 2023; 17():191-207. PubMed ID: 36718245 [TBL] [Abstract][Full Text] [Related]
19. Validation of a pharmacokinetic model of colon-specific drug delivery and the therapeutic effects of chitosan capsules containing 5-aminosalicylic acid on 2,4,6-trinitrobenzenesulphonic acid-induced colitis in rats. Tozaki H; Fujita T; Odoriba T; Terabe A; Okabe S; Muranishi S; Yamamoto A J Pharm Pharmacol; 1999 Oct; 51(10):1107-12. PubMed ID: 10579681 [TBL] [Abstract][Full Text] [Related]
20. Effect of surface chemistry on nanoparticle interaction with gastrointestinal mucus and distribution in the gastrointestinal tract following oral and rectal administration in the mouse. Maisel K; Ensign L; Reddy M; Cone R; Hanes J J Control Release; 2015 Jan; 197():48-57. PubMed ID: 25449804 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]